2006
DOI: 10.1111/j.1600-0420.2005.00610.x
|View full text |Cite
|
Sign up to set email alerts
|

Clinical evaluation of rebound tonometer

Abstract: ABSTRACT.Purpose: To evaluate the reliability and repeatability of intraocular pressure (IOP) measurements using a new rebound tonometer. Methods: Intraocular pressure was measured in 42 healthy human eyes of subjects aged 18-30 years (mean ± standard deviation [SD] 21.5 ± 3.2 years) using the ICare Rebound and Goldmann tonometers in two separate sessions. Results: Intraocular pressure measurements were found to read slightly, but not significantly, higher with the ICare tonometer compared with the Goldmann in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
72
1
2

Year Published

2007
2007
2012
2012

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 103 publications
(81 citation statements)
references
References 20 publications
6
72
1
2
Order By: Relevance
“…The Icare (Icare Finland Oy, 02600 Espoo, Finland) is a modern rebound tonometer that does not need topical anaesthesia to obtain a measurement. [3][4][5][6][7] The tonometer is based on a new measuring principle, in which a very lightweight probe makes momentary contact with the cornea. It can be used by assistant medical staff 8 and shows a degree of agreement with Goldmann applanation tonometer (GAT), that is satisfactory for the purposes of identifying cases of significant elevation of intraocular pressure (IOP).…”
Section: Introductionmentioning
confidence: 99%
“…The Icare (Icare Finland Oy, 02600 Espoo, Finland) is a modern rebound tonometer that does not need topical anaesthesia to obtain a measurement. [3][4][5][6][7] The tonometer is based on a new measuring principle, in which a very lightweight probe makes momentary contact with the cornea. It can be used by assistant medical staff 8 and shows a degree of agreement with Goldmann applanation tonometer (GAT), that is satisfactory for the purposes of identifying cases of significant elevation of intraocular pressure (IOP).…”
Section: Introductionmentioning
confidence: 99%
“…1,[8][9][10][11] In the current study using IOPen, the median IOP was 3 mm Hg lower than the GAT or ORA IOPs. Other studies of the ICare reported that 63.2% of cases had IOP values that differed from the IOP values obtained with GAT by 3 mm Hg or less, a limit considered clinically relevant.…”
Section: Discussionmentioning
confidence: 99%
“…In five studies 145,165,189,190,209 (36%), cases were selected consecutively. In eight studies 106,145,154,165,190,[209][210][211] (57%), individual measures taken within 1 hour were reported and the same clinical data were available for interpretation as would be in clinical practice. Ten studies 106,107,145,154,165,167,184,207,209,211 (71%) reported whether or not the examiner(s) were masked to the results.…”
Section: Rebound Tomometermentioning
confidence: 99%
“…In eight studies 106,145,154,165,190,[209][210][211] (57%), individual measures taken within 1 hour were reported and the same clinical data were available for interpretation as would be in clinical practice. Ten studies 106,107,145,154,165,167,184,207,209,211 (71%) reported whether or not the examiner(s) were masked to the results. In seven studies 106,107,145,165,207,209,211 (50%), the tonometers used were calibrated.…”
Section: Rebound Tomometermentioning
confidence: 99%
See 1 more Smart Citation